.After leaving a scientific grip a number of years back, Dyne Therapy has actually shown new phase 1...
.Arrowhead Pharmaceuticals has shown its hand in advance of a possible face-off along with Ionis, re...
.Pfizer and Valneva might possess concerning 2 even more years to hang around before they make the 1...
.Let's dive into a chat with Ayla Ellison, Tough Biotech Editor-in-Chief as well as Michelle Benz as...
.Bayer put on hold the phase 3 trial for its own variable XIa prevention asundexian behind time in 2...
.Sanofi is still set on taking its various sclerosis (MS) med tolebrutinib to the FDA, execs have ac...
.Galapagos is actually happening under additional pressure from entrepreneurs. Having actually const...
.Invite to this week's Chutes & Ladders, our summary of substantial management hirings, shootings...
.Shanghai Allist Pharmaceuticals has bought on its own a starring role in China's KRAS market, payin...
.ReNeuron has participated in the long listing of biotechs to leave behind Greater london's objectiv...